The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
https://www.beckman.com/contact-us/india
Jigsaw pieces starting to fit. Beckman Coulter specialize in advancing and optimizing the laboratory.
We just heard recently about the upcoming Divoc Lab.
https://www.divoc.health/divoc-lab.html
https://healthvision.in/covid-testing-logistical-challenges-and-how-to-address-them/
We are DIVOC Health
DIVOC Health is formed to reverse the COVID19 Pandemic. Using Innovative Products and approaches, DIVOC aims to address needs of the Indian healthcare market. DIVOC Health is a a new enterprise bringing innovative healthcare products into the Indian Market established by Dr Kanav Kahol, a former professor from Arizona State University and Mayo Clinic USA and a renowned healthcare innovator in partnership with Lion’s Head Global Partners. To address the Immediate need for India to have access to high quality COVID19 Tests DIVOC is bringing GeneDrive RT PCR COVID19 Tests to India. The availability of accurate, high quality tests is critical part of India’s defence against Covid19. We identified the Genedrive test as being particularly well suited to the Indian market due to its thermostability, reduced processing steps and high quality manufacture. DIVOC has applied for regulatory clearance in India. The Indian regulatory process has recently been amended and now requires successful performance evaluation by the Indian Council of Medical Research, which DIVOC is pursuing. The Company is optimistic that India registration could be obtained. DIVOC is also working on healthcare delivery models that will enable quality healthcare to be delivered through technology.